PortfoliosLab logo

ADMA Biologics, Inc. (ADMA)

Equity · Currency in USD · Last updated Feb 7, 2023

Company Info

ISINUS0008991046
CUSIP000899104
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$3.71
Year Range$1.43 - $3.88
EMA (50)$3.48
EMA (200)$2.74
Average Volume$3.22M
Market Capitalization$830.60M

ADMAShare Price Chart


Loading data...

ADMAPerformance

The chart shows the growth of $10,000 invested in ADMA Biologics, Inc. in Sep 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $4,417 for a total return of roughly -55.83%. All prices are adjusted for splits and dividends.


-20.00%-10.00%0.00%10.00%20.00%30.00%40.00%OctoberNovemberDecember2023February
37.95%
3.64%
ADMA (ADMA Biologics, Inc.)
Benchmark (^GSPC)

ADMACompare to other instruments

Search for stocks, ETFs, and funds to compare with ADMA

ADMA Biologics, Inc.

ADMAReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M2.20%5.55%
YTD-4.38%7.07%
6M73.36%-0.82%
1Y131.88%-8.65%
5Y-0.48%8.83%
10Y-8.55%9.23%

ADMAMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2023-4.90%
202226.17%-10.00%16.05%18.44%16.17%

ADMASharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current ADMA Biologics, Inc. Sharpe ratio is 2.04. A Sharpe ratio higher than 2.0 is considered very good.

The chart below displays rolling 12-month Sharpe Ratio.


-1.000.001.002.003.00OctoberNovemberDecember2023February
2.04
-0.34
ADMA (ADMA Biologics, Inc.)
Benchmark (^GSPC)

ADMADividend History


ADMA Biologics, Inc. doesn't pay dividends

ADMADrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%OctoberNovemberDecember2023February
-70.30%
-14.29%
ADMA (ADMA Biologics, Inc.)
Benchmark (^GSPC)

ADMAWorst Drawdowns

The table below shows the maximum drawdowns of the ADMA Biologics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the ADMA Biologics, Inc. is 91.27%, recorded on Oct 11, 2021. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-91.27%Nov 26, 20141727Oct 11, 2021
-20.47%Nov 19, 201324Dec 23, 201316Jan 27, 201440
-18.89%Mar 4, 201440May 12, 201412Jun 3, 201452
-12.38%Jul 10, 201433Aug 27, 201425Oct 2, 201458
-6.81%Oct 7, 20141Oct 7, 20145Oct 14, 20146
-6.78%Jan 28, 20145Feb 3, 201419Mar 3, 201424
-6.53%Jun 23, 20142Jun 24, 20147Jul 7, 20149
-6.47%Oct 29, 201311Nov 12, 20134Nov 18, 201315
-5.54%Nov 12, 20148Nov 21, 20142Nov 25, 201410
-4.21%Jun 4, 20146Jun 13, 20141Jun 17, 20147

ADMAVolatility Chart

Current ADMA Biologics, Inc. volatility is 27.12%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%120.00%140.00%OctoberNovemberDecember2023February
27.12%
16.98%
ADMA (ADMA Biologics, Inc.)
Benchmark (^GSPC)